tiprankstipranks
Trending News
More News >
Aclaris Therapeutics initiates Phase 2 trial of bosakitug
PremiumThe FlyAclaris Therapeutics initiates Phase 2 trial of bosakitug
1M ago
Optimistic Buy Rating for Aclaris Therapeutics Driven by Promising Dermatology Pipeline Developments
Premium
Ratings
Optimistic Buy Rating for Aclaris Therapeutics Driven by Promising Dermatology Pipeline Developments
1M ago
Wedbush bullish on Aclaris Therapeutics, initiates with an Outperform
Premium
The Fly
Wedbush bullish on Aclaris Therapeutics, initiates with an Outperform
1M ago
Aclaris Therapeutics price target lowered to $9 from $15 at Scotiabank
PremiumThe FlyAclaris Therapeutics price target lowered to $9 from $15 at Scotiabank
2M ago
Aclaris Therapeutics Reports Q1 2025 Financial Results
Premium
Company Announcements
Aclaris Therapeutics Reports Q1 2025 Financial Results
2M ago
Aclaris Therapeutics reports Q1 EPS (12c), consensus (12c)
Premium
The Fly
Aclaris Therapeutics reports Q1 EPS (12c), consensus (12c)
2M ago
Tesla upgraded, Coinbase initiated: Wall Street’s top analyst calls
PremiumThe FlyTesla upgraded, Coinbase initiated: Wall Street’s top analyst calls
4M ago
Aclaris Therapeutics initiated with an Outperform at Scotiabank
Premium
The Fly
Aclaris Therapeutics initiated with an Outperform at Scotiabank
4M ago
Aclaris Therapeutics: Strong Pipeline and Financial Stability Justify Buy Rating
Premium
Ratings
Aclaris Therapeutics: Strong Pipeline and Financial Stability Justify Buy Rating
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100